A Phase 1/2 Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Patients With Advanced Carcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 28 Nov 2013
At a glance
- Drugs Aflibercept; Cisplatin; Pemetrexed
- Indications Cancer; Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2013 Status changed from completed to discontinued according to results published in the British Journal of Cancer.
- 10 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jan 2012 Last checked against ClinicalTrials.gov record.